Holding(s) in Company
On October 6, 2025, Immupharma PLC announced that Lanstead Capital Investors LP crossed a threshold related to major holdings. The notification, dated October 2, 2025, reveals that Lanstead Capital Investors LP now holds 4.99% of the voting rights attached to shares, a decrease from the previously notified 8.99%. This change reflects a holding of 25,108,044 ordinary shares out of a total of 502,723,932 voting rights attached to shares. The notification indicates an acquisition or disposal of voting rights as the reason for the change.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Lanstead Capital Investors LP |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 2/10/2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 6/10/2025 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 4.99% | 0.00% | 4.99% | 502,723,932 |
| Position of previous notification (if applicable) | 8.99% | 0.00% | 8.99% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | |
| Ordinary Shares ISIN: GB0033711010 | 25,108,044 | 0 | 4.99% | 0.00% |
| SUBTOTAL 8. A | 25,108,044 | 4.99% | ||
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
N/A
SUBTOTAL 8. B 1
N/A
SUBTOTAL 8.B.2
N/A
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | LON |
| Date of completion | 6/10/2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.